Megadose Methyl-Prednisolone (MDMP) for Autoimmune Hemolytic Anemia
Journal Title: Turkish Journal of Hematology - Year 2013, Vol 30, Issue 2
Abstract
To the Editor, Üsküdar Teke and colleagues originally used 1 mg kg–1 day–1 methylprednisolone (MDMP) for their patient with autoimmune hemolytic anemia without improvement, and after 3 weeks of steroid treatment splenic infarct developed.The patient was splenectomized but the hemolytic anemia again did not improve. Therefore, azathioprine was prescribed [1].
Authors and Affiliations
Şinasi Özsoylu
The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients
Objective: The purpose of this study is to investigate the relationship between the CD56 and CD117 expressions and the clinical and laboratory findings in multiple myeloma (MM) patients. Materials and Methods: Analyses...
Hiperkalsemi Saptanan Hemodiyaliz Hastasında Nonsekretuar Multipl Miyelom Tanısı
Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis
Objective: Transformed mycosis fungoides (T-MF) is a rare variant of MF with an aggressive course. In this study, we aimed to describe characteristics of MF/Sezary syndrome (SS) patients with transformation. Materials an...
Autoerythrocyte Sensitization Syndrome Treated with Kallikrein Inhibitor
To the Editor, I read the letter related to autoerythrocyte sensitization syndrome in a 7-year-old boy published in the Turkish Journal of Hematology [1]. I would like to remark on a few points that were not mentioned i...
Diagnosis: Congenital Dyserythropoietic Anemia Type 2 Due to Compound Heterozygote Mutation in SEC23B Gene